Granules India Ltd. announced that, its Gagillapur
facility (Gagillapur Village,
Dundigal-Gandimaisamma Mandal, Medchal-Malkajgiri District, Telangana, India)
received ‘Form 483’ with six observations. Granules India manufactures 21 of
the total 54 formulation products manufactured for the US market. This facility
manufactures Oral Solids.